Collaboration with Oragenics on human TOP3B inhibitors Grant

date/time interval

  • May 5, 2022 - August 1, 2024

awarded by

sponsor award ID

  • AGM-1761 TASK ORDER 2

local award ID

  • AWD000000014636

contributor